A review of the common properties of drugs with idiosyncratic hepatotoxicity and the “multiple determinant hypothesis” for the manifestation of idiosyncratic drug toxicity
- 1 October 2002
- journal article
- review article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 142 (1-2) , 7-23
- https://doi.org/10.1016/s0009-2797(02)00051-0
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Felbamate in Epilepsy TherapyDrug Safety, 1999
- Pharmacokinetic Interactions with FelbamateClinical Pharmacokinetics, 1997
- Evaluation of Pharmacokinetic Interaction Between Bromfenac and Phenytoin in Healthy MalesThe Journal of Clinical Pharmacology, 1997
- Inhibition of N‐Acetylation of Procainamide and Renal Clearance of N‐Acetylprocainamide by Para‐Aminobenzoic Acid in HumansThe Journal of Clinical Pharmacology, 1995
- Identification of 3α-hydroxy-cyproterone acetate as a metabolite of cyproterone acetate in the bile of female rats and the potential of this and other already known or putative metabolites to form DNA adducts in vitroCarcinogenesis: Integrative Cancer Research, 1995
- Ketoconazole-induced fulminant hepatitis necessitating liver transplantationJournal of the American Academy of Dermatology, 1991
- Pharmacokinetic Drug Interactions with Nonsteroidal Anti-Inflammatory DrugsClinical Pharmacokinetics, 1990
- Halothane and HepatitisDrug Safety, 1990
- Clinical Pharmacokinetics of the SalicylatesClinical Pharmacokinetics, 1985
- Nonspecific Stimulation of Drug Metabolism in Rats by MethoxyfluraneAnesthesiology, 1970